[Federal Register: January 4, 2005 (Volume 70, Number 2)]
[Notices]
[Page 389]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ja05-73]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 21, 2004, and published in the Federal
Register on August 10, 2004, (69 FR 48521-48522), Cayman Chemical
Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
------------------------------------------------------------------------
The company plans to manufacture small quantities of marihuana
derivatives for research purposes.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-68 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P